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ABSTRACT 
 
   Increased fractionation spares late reacting normal tissues more than acute reacting normal tissues. 
A linear quadratic model is valid from large dose per fraction down to dose per fraction of 2 Gy. 
Experimental studies on animals and clinical studies on the spinal cord tolerance have shown 
incidences of myelopathy at doses lower than 50 Gy. The α/β value of the linear quadratic model have 
been lower for low doses per fraction, indicating a sparing effect of altered fractionation for spinal cord 
myelitis. Animal data, clinical and radiobiological explanations suggest limitation of the radiobiological 
models. Further data suggest that one must not assume the spinal cord to have a greater tolerance 
at doses per fraction below the conventional dose per fraction of 2 Gy. 
 
 
INTRODUCTION 
 
   In fractionated radiotherapy, the total 
dose required to induce a certain effect 
on the tissue, generally increases when 
the size of the dose per fraction decre-
ases; this is due to recovery of sublethal 
damage during interval between irradia-
tion. 
   There is evidence that late reacting 
normal tissue benefit relatively more from 
smaller fractions than rapidly proliferating 
tissues. From the studies of normal tissue 
which have been reported so far, it can be 
concluded that the dose fractionation res-
ponse is described accurately by the Li-
near Quadratic (LQ) model over the radia-
tion dose range from large single doses 
down to dose per fraction of about 2 Gy. 
   Below 2 Gy per fraction, the limited data 
from literature have been controversial 
and cast some doubt on the validity 
as well as the applicability of the LQ mo-
del. For late normal tissue damage the re-
ported values for α/β are quite small, indi-
cating a large capacity for repairing sub-
lethal damage. 
   The introduction of altered fractionation 
schedules in clinical radiotherapy is an ex-
ample of how contributions from radiobio-
logical research and clinical observations 
can lead to the development of novel 
treatment strategies. The observations 
that tissues with different turnover kinetics 
respond differently to changes in dose 
fractionation and protection of radiothe-
rapy form the basis of attempting to im-
prove outcome by altering radiotherapy 
schedules. 
   The two basic approaches that offer 
the prospects of some improvement 
in the therapeutic ratio between tumour 
control and late complications are: 
a. Accelerated fractionation, for which 
the overall time of treatment is signify-
cantly reduced, while the dose per 
fraction and the total dose are slightly 
reduced compared with the conven-
tional schedule. 
b. Hyperfractionation, by using a dose 
per fraction smaller than that employed 
in a conventional schedule without 
changing the overall treatment time, 
which results in an increased total 
dose. Although the rationale is diffe-
rent, it is necessary to deliver several 
treatments per day with both strate-
gies. 
   Information on the rate of repair in va-
rious tissues is, therefore, essential for se-
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lecting an appropriate interval between 
radiation doses in specific situations. In or-
der to accommodate such a requirement 
in a clinical department the interval bet-
ween fractions has been reduced from 
the conventional 24 hrs to no more than 
3-6 hrs, depending on the type of treat-
ment schedule employed. 
   These logistic constraints may jeopar-
dise the potential benefit of altered fra-
ctionation schedules if they compromise 
the normal tissue tolerance with a larger 
extent than they affect tumour control 
probability because of incomplete repair 
between fractions. 
   Radiation myelopathy is one of the deva-
stating complications of clinical radiothe-
rapy. The spinal cord is, therefore, one 
of the major dose limiting organs in clinical 
radiotherapy. Indeed, a number of patients 
have recently been reported to have 
developed radiation myelopathy following 
hyperfractionated accelerated radiothe-
rapy (Dische and Saunders [5], Dische [6], 
Jeremic et al. [8]). In view of the current 
interest in hyperfractionation and acce-
lerated fractionation, and increasing 
application of the LQ model to clinical 
radiotherapy, further data are clearly 
desirable. This review presents the expe-
rimental, radiobiological and clinical as-
pects of radiation myelopathy for altered 
fractionation schedules. 
 
 
Linear Quadratic model for multiple 
daily fractionation 
   Dale [4] has further applied the LQ 
equation to fractionated radiotherapy when 
there is incomplete normal tissue recovery 
between fractions, and possible impli-
cation for treatment involving multiple 
fractions a day. He derived a general 
equation for RE for fractions of dose d, 
each fraction given after a time interval 
of x hr: 
Re =1 + (β/α) (d/n) [{n(1-k2) – 2k (1-kn)} / (1-k)2], 
where k = exp (-µx) = e(-µx) 
   Thames [13] has proposed an incomple-
te repair model for multiple fractions a day 
as: 
   TE = (α/β + d + d * hm) *D, 
where hm is the incomplete repair factor, 
the values of hm for two and three fractions 
a day having been tabulated. 
   Supe [12] has derived RE equations 
for 2 and 3 fractions per day as 
RE2 = 1 + d(β/α) (1 + e(-µx)), 
RE3 =1 + d(β/α) (d/3) (3+4 e(-µx) + 2 e(-2µx)). 
   Ang [2] has commented on the lack 
of evidence for increased tolerance of rat 
spinal cord with decreasing fraction doses 
below 2 Gy. Rats were irradiated with 
18 MV photons for the cervical spinal cord. 
To assess the effect of small radiation 
doses, on the spinal cord, four fraction 
sizes of 1.3 Gy,1.5 Gy, 1.8Gy and 2 Gy 
were investigated. A constant top up dose 
of 15 Gy was given. The overall treatment 
time was kept between 6 to 8 weeks. 
The percentage of animals in each dose 
group that developed white matter 
necrosis was used for constructing dose 
response curves from which the ED50 
values were calculated by probit analysis. 
The isoeffect doses as a function of dose 
per fraction, as predicated by Ellis type 
isoeffect formula as well as Linear 
Quadratic (LQ) model and results of Ang's 
study, are summarized in Table 1. 
 
Table 1. ED50 at different fraction sizes. 
Dose per fraction (Gy/fr.) 2 1.8 1.5 1.3 
Ang 70 62.2 68.8 <75 
Prediction by formula DN0.43 76 83 95 105 
Prediction by LQ model (α/β) 1.7Gy 72 76 84 89 
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   Both the Ellis type formula and the LQ 
model predict a continuously increasing 
tolerance dose with decreasing fraction 
size. A consequence of the present finding 
would be a cautious use of alpha/beta 
ratios for predicting isoeffect doses at fra-
ction size smaller than those which expe-
rimental and clinical data can predict. 
   Van der Schueren et al. [15] has showed 
the influence of reducing the dose per 
fraction from 2 Gy down to 1 Gy on the ra-
diation response of the rat cervical spinal 
cord. The radiation treatments were 
carried out with 18 MV photons. A con-
stant top up dose of 15 Gy was delivered, 
the total treatment time being 4-6 weeks. 
The end-point of the experiments was 
foreleg paralysis due to demyelination 
and white matter necrosis. The ED50 
values were calculated by a probit 
analysis. Experimental ED50 values along 
with predictions of the LQ model are 
shown in Table 2. 
Table 2. ED50 (Gy) for rat cervical spinal cord. 
 
(Dose per fraction (Gy/fr.)) 2 1.8 1.5 1.3 1.0 
Exp.data 140 124.4 137.6 <150 159.1 
Estimations LQ model 
(α/β = 1.7 Gy) 
- 148.5 162.4 173.3 192.5 
 
   Small but probably significant rise in to-
lerance was suggested, when the dose 
per fraction was decreased from 2 Gy 
to 1 Gy. This rise would now be still much 
less than that predicted by the LQ model, 
based on the experimental data obtained 
from fraction sizes larger than 2 Gy. 
The repair of sublethal radiation damage 
in the rat spinal cord in hyperfractionation 
experiments is incomplete for the dose per 
fraction between 2 Gy and 1 Gy.  
   Lavey et al. [9] has undertaken a study 
to determine the extent to which hyperfra-
ctionation may spare the spinal cord 
as well as increase the latent period 
for the development of transverse myelitis. 
The spinal cord of mice was irradiated with 
a conventionally fractionated regimen 
of 2 Gy once daily or a hyperfractionated 
regimen of 1.2 Gy twice daily separated by 
8 hrs. A top up dose of 15 Gy was given. 
   Overall, the spinal cord was not spared 
by hyperfractionation to the extent pre-
dicted by the Ellis or LQ model. The thre-
shold dose was higher in the hyperfractio-
nated than in the conventionally fractio-
nated group. The latent period and ED50 
did not significantly differ between the two 
regimens. 
   The continuation of the process of sub-
lethal damage repair in the spinal cord 
beyond 8 hrs after irradiation may have 
influenced these results. The slow com-
ponent of SLD repair should be conside-
red in the design of hyperfractionated 
or accelerated radiation therapy schedules 
for clinical use. 
   Data from the mouse and the rat as well 
as human clinical trials do not support 
the use of hyperfractionated radiation 
schedules with short interfraction intervals 
aimed at delivering higher doses 
to the spinal cord than would otherwise 
be considered safe with conventional 
fractionation. Additional work is required 
to confirm the suggestion that hyperfrac-
tionation significantly increases the thre-
shold dose for the induction of radiation 
myelitis. 
   Niewald et al. [10] has examined in rats 
whether the radiation tolerance of the spi-
nal cord is enhanced by using hyper-
fractionated radiotherapy compared with 
a conventional schedule. Cervical spinal 
cords of 276 healthy rats were irradiated 
over 6 weeks hyperfractionally with single 
doses, varying from 0.75-2.5 Gy up to total 
doses ranging from 45-150 Gy (66 fra-
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ctions) and conventionally with single 
doses of 1.5-4.0 Gy up to total doses 
of 45-120 Gy (30 fractions). The rats were 
examined neurologically and were sacri-
ficed when paralysis of the hind leg 
occurred. After fixation the spinal cord was 
removed and examined histologically. 
Dose effect relationship and latency from 
the beginning of radiotherapy to the onset 
of paralysis were computed and analysed 
using a multivariate logistic regression 
model. The model fitted the data exce-
llently (Table 3). 
Table 3. Rate of myelopathy for conventional fractionation and hyperfractionation. 
 
Rate of myelopathy 
Dose (Gy) 
Conventional fractionation Hyperfractionation 
45.0 0.00 0.00 
52.5 0.00 - 
60.0 0.18 0.11 
67.5 0.00 - 
75.0 0.82 0.22 
82.5 0.75 0.10 
90.0 1.00 0.40 
97.5 1.00 0.20 
105.0 - 1.00 
120.0 - 1.00 
135.0 - 1.00 
150.0 - 1.00 
 
   There were highly significant results both 
for the dose level and for the treatment 
regimen. A latency analysis showed earlier 
and more intense acute side effects after 
hyperfractionation, but radiomyelopathy 
occurred markedly later. 
   These results show that, compared with 
conventional fractionation, a distinctly hig-
her dose of 28% could be applied using 
hyperfractionated radiotherapy at the 50% 
level of damage; at the 5% level of da-
mage a 39% higher dose could be applied. 
This finding fits well with that of the litera-
ture. For experimental purposes these 
values seem suitable. The sparing effect 
of hyperfractionation on the spinal cord 
as predicted by radiobiologists was confir-
med. Thus it seems possible to escalate 
tumour doses using hyperfractionation 
without an enhanced risk to late respon-
ding tissues. 
 
Dependence of LQ model parameters 
on dose per fraction 
   Ang et al. [3] investigated the possible 
dependency of the kinetics of repair 
of the sublethal damage in the rat spinal 
cord on the fraction size. A wide range 
of doses per fraction (1.5-17.5 Gy) was 
given, with interfraction interval varying 
from 0.5 to 24 hrs. A direct method 
for the analysis of quantal response and 
an incomplete repair model for survival 
after fractionated exposures with shorter 
intervals were used to interpret the data 
(Table 4). There appeared to be no signi-
fycant effect of fraction size on the rate 
of repair. 
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Table 4. Effect of fraction size on repair kinetics. 
 
Dose/fr (Gy) α/β (Gy) T1/2 (hr) 
1.7 – 5.1 2.7 1.6 
6.2 – 12 2.0 1.6 
11.5 – 17.5 2.7 1.9 
 
   Another feature in the analysis of results 
is that the alpha/beta determined from 
the complete repair data (1.7 Gy) is con-
siderably smaller than that estimated from 
the incomplete repair data (4.3 Gy). 
   Wong [18] has described results of a se-
ries of experiments which were designed 
to assess the radiation response 
of the spinal cord at fraction sizes down 
to 0.55 Gy given once daily. All irradiation 
were carried out with 100 kV X rays. 
For the cervical spinal cord, alpha/beta 
values were evaluated for three dose per 
fraction ranges as shown in Table 5. 
 
Table 5. Alpha/beta values for different dose per fractions. 
 
Dose / fr (Gy) α/β (Gy) 
25.0 – 1.98 2.41 
10.0 – 1.64 3.41 
1.60 – 0.55 0.48 
 
   The LQ model based on the large dose 
per fraction data underestimates the spa-
ring effects of small doses per fraction, 
provided sufficient time is allowed between 
each fraction for repair of the sublethal 
damage. 
   Wong [17] has commented on the res-
ponse of the rat spinal cord to very small 
doses per fraction. The rat spinal cord was 
irradiated with a top up dose of three daily 
doses of 10.25 Gy, followed by graded 
single doses or fractionated doses. 
The endpoint was forelimb paralysis 
secondary to white matter necrosis 
confirmed histologically. Alpha/beta values 
were evaluated for two dose per fraction 
ranges (Table 6). The study provided no 
evidence for of an increase in the radio-
sensitivity of the rat spinal cord below 1 Gy 
down to 0.4 Gy per fraction. 
 
Table 6. Alpha/beta values for different dose per fraction. 
 
Dose / fr (Gy) α/β (Gy) 
1.79 – 25.0 2.46 
0.41 – 1.78 1.50 
 
   Thames [14] has commented on whe-
ther incomplete repair explains the appa-
rent failure of the basic LQ model to pre-
dict spinal cord and kidney responses 
to low fraction doses. His findings are 
given in Table 7. 
 
Table 7. Repair capacity and kinetics after multiple day 
experiments. 
 
 Spinal cord 
10 alpha (Gy-1) 0.70 
100 beta (Gy-2) 2.60 
Alpha / Beta (Gy) 2.7 
T1/2 (hr) 1.64 
 
   For the spinal cord, the data could be 
interpreted by assuming that the repair 
process with a half time of 1.7 hrs was 
incomplete. This half time is negligibly 
different from the estimate obtained from 
repair kinetics experiments with a larger 
dose per fraction. The clinical implications 
could be that multiple fractions per day 
treatment would benefit from the use 
of the largest feasible interfraction interval 
when late reactions are dose limiting. 
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   The sparing effects of hyperfractionation 
on the spinal cord, as predicted by ra-
diobiologists, could be confirmed by this 
experiment. Thus it seems possible to es-
calate tumour doses using hyperfra-
ctionation without an enhanced risk 
to the spinal cord but with higher pro-
bability of tumour cure. 
 
Radiobiological explanation for spinal 
cord myelitis in clinical radiotherapy 
   Jeremic [8] has investigated whether 
the thoracic spinal cord dose of 50.4 Gy 
given via 1.2 Gy per fraction, two fractions 
per day, carries a risk of developing radia-
tion myelitis in studies using hyperfractio-
nated radiation therapy with and without 
concurrent chemotherapy. Three hundred 
patients with stage III non-small cell lung 
cancer (NSCLC) were treated on in two 
consecutive phase II studies, 158 patients 
received 50.4 Gy to a portion of their 
spinal cord and survived >1 year after 
the beginning of the therapy. The interfra-
ction interval varied from 4.5 to 6.0 hrs 
Therefore the influence of potentially 
contributing factors on the occurrence 
of radiation myelitis, such as interfraction 
interval or those unproven yet such 
as cord length or administration of con-
current chemotherapy, could not be deter-
mined. Given the continuing interest 
in HFX RT and encouraging results 
obtained in studies on lung cancer, further 
investigation is needed to get more 
information about the risk of developing 
thoracic radiation myelitis with this cord 
dose. 
   Dische [5] has published an interim 
report upon late morbidity for continuous, 
hyperfractionated accelerated radiothe-
rapy (CHART). 206 patients of advanced 
head and neck cancer received either 
a total dose of 50.4 Gy at dose per fraction 
of 1.4 Gy, or 54 Gy at dose per fraction 
of 1.5 Gy (3 fr/day with 6 hrs interval). 
Employing the alpha/beta ratio of 2.5, 
a dose increment of 1.5 Gy and a total 
dose of 42 Gy, the LQ equation gives 
a result of 64.2 alpha damage units, 
and this can be compared with 72 alpha 
damage units for 40 Gy given in 2 Gy 
increments. 
   With a small dose increment and a limi-
ted total dose of radiation in the CHART 
regime there seemed to be a good reserve 
of tolerance in the spinal cord. It is of rele-
vance that there are uncertainties 
as to the existence of further sparing 
below a dose per fraction of 2 Gy. 
   In general, the impression that late 
damage with smaller fractions is lower 
than that after conventional radiotherapy 
is sustained. Two patients who developed 
myelitis presented with advanced tumours 
which responded well. A modification 
to avoid myelitis is essential as is also 
the pursuits of CHART as part of the effort 
to improve tumour control by modification 
of the programming of radiotherapy. 
 
Radiobiological explanation for spinal 
cord myelitis in clinical radiotherapy 
   Guttenberger [7] has introduced a new 
incomplete repair model by assuming 
that repair is complete during long inter-
vals, e.g. overnight intervals of 12-24 hrs. 
The model was used to assess the risk 
of myelopathy resulting from continuous 
hyperfractionated accelerated radiothe-
rapy (CHART) in the light of recent 
experimental data on the rat spinal cord. 
Computer simulations were carried out 
using alpha/beta of 2 Gy. Model calcu-
lations employing an incomplete repair 
model and bi-exponential repair kinetics 
showed that the CHART treatments might 
result in a higher myelopathy risk than 
an equal dose given in conventional 2 Gy 
fractions if the parameters obtained from 
the animal data hold. From computer 
simulations a myelopathy risk of appro-
ximately 0.3-1.2% is predicted for the cu-
rrently employed maximum CHART dose 
to the spinal cord, i.e. 42 Gy. 
   The CHART experience is not compa-
tible with the new experimental data. 
Incomplete repair is unlikely to be the sole 
reason for the unexpected toxicity 
of CHART. However the compounding 
effect of incomplete repair could be mini-
mised by rearranging the modified CHART 
schedule which would result in an increase 
of the tolerance dose by approximately 
10%. 
   Wong [16] has offered a radiobiological 
interpretation of meylopathy in hyper-
fractionated accelerated radiotherapy. 
From 1975 to 1982, 32 patients with a dia-
gnosis of anaplastic carcinoma of the thy-
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roid were entered into a protocol of hyper-
fractionated accelerated radiotherapy. 
The tumour dose was 35-40 Gy at 1 Gy 
per fraction given 4 times a day at 3 hr 
intervals. Two patients developed radiation 
myelopathy at 8 and 13 months, total 
spinal cord doses being 39.9 and 48.3 Gy, 
respectively. The risk of spinal cord 
damage was much higher than expected. 
   The spinal cord doses for patients with 
myelopathy were 5 Gy + 35Gy/ 35 fr/ 11 
days, gap 21 days, 5 Gy + 45 Gy/ 45 fr/ 16 
days, gap of 13 days. Neurological sym-
ptoms indicated that the two patients had 
myelopathy. The neurological symptoms 
and signs were consistent with the ana-
tomic level of the spinal cord irradiated. 
   The spinal cord doses of the two pa-
tients were recalculated using the incom-
plete repair model described by Thames 
[14]. Dose equivalent in alpha damage 
units was calculated using an alpha/beta 
ratio of 2,3 and 4 Gy and repair half time 
of 1.5, 2 and 3 hr. As a consequence 
of the shortened interfraction interval, 
the incomplete repair model seems 
to increase the radiation effects in terms 
of alpha damage units by 7% using a re-
pair half time of 1.5 hr and as much 
as 35% with the repair half time of 3 hr. 
When the accepted spinal cord tolerance, 
i.e., 50 Gy in 2 Gy daily fractions, was 
compared with the two cases in terms 
of alpha damage units, even corrected 
for the lack of incomplete repair, case 
1 in fact received a dose well below what 
is generally accepted to be the tolerance 
dose for the spinal cord, and case 2 re-
ceived a cord dose approaching the cord 
tolerance using the repair half time 
of 1.5 hr and 2 hr, respectively. When 
the repair half time of 3 hr was used 
in the calculations the cord dose exceeded 
the cord tolerance. This repair time 
is much greater than the values obtained 
from the spinal cord. 
   In the continuous hyperfractionated 
accelerated radiotherapy (CHART) regime 
at the Mount Vernon Hospital, Middlesex, 
England, there have been four cases 
of radiation myelopathy with doses of 46.0, 
45.2, 48.3 and 46.6 Gy. All 6 patients 
developed radiation myelopathy at the spi-
nal cord doses which were considered 
to be well within the spinal cord tolerance. 
There was no apparent explanation 
for the spinal cord damage seen. These 
cases, therefore, raise serious concerns 
about the underlying radiobiological model 
upon which these altered fractionation 
schemes are based. 
   To conclude, observations of 6 myelo-
pathy cases in patients treated with 
hyperfractionated accelerated radiothe-
rapy and recent animal data both suggest 
limitations of the LQ or IR model and in-
dicate that these models should be used 
with caution to predict spinal cord tole-
rance doses for altered fractionation regi-
mens in clinical radiotherapy. 
 
CONCLUSION 
 
   Currently accepted practice regarding 
radiation doses delivered incidentally 
to the spinal cord is evidence of more 
radiation oncologists' intolerance of radia-
tion myelopathy than of the spinal cord's 
intolerance to radiation. Furthermore, 
excessive dependence upon published 
or personal anecdotes has generated 
a myth that has moved the discussion 
of the spinal cord response away from 
scientific dialogue towards catechisms. 
   We must be cautious in the interpre-
tation of clinical reports where there 
is a low incidence of complication of treat-
ment, for there is always a possibility 
of technical error, complicating factor and 
unusual sensitivity. Radiation myelopathy 
is, however, a most serious occurrence 
following radiotherapy and even a low 
incidence associated with a new regime 
must be carefully considered. 
   The rare myelopathies that occur at low 
doses (<=45 Gy) are seen for three 
reasons: 
a. Extrinsic factors reduce some indivi-
dual's radiation tolerance, 
c. Tens of thousands of patients are irra-
diated annually at these doses, 
and 
c. The true dose was larger than that esti-
mated. 
   The clinical observations have also un-
derscored the importance of obtaining ra-
diobiological data in clinically relevant do-
se fractionation schemes to confirm or re-
fute predictions from biological models. 
The ultimate test for the validity of a biolo-
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gical model are, however, clinical observa-
tions. 
   However, the final model is the patient 
undergoing radiotherapy and this expe-
rience underlines the need for a very 
careful observation of patients entered into 
clinical trials of methods to improve 
the effectiveness of treatment. Normal 
tissue effects must be observed with 
the same meticulous care given to tumour 
control. It is most important that promising 
methods for improvement of tumour con-
trol must be abandoned because of such 
problems. 
   Knowledge gained from the laboratory 
and the clinic must be applied to the pre-
ventionaI morbidity and advance in mana-
gement. 
   Recent evidence has indicated that 
the isoeffect dose for the spinal cord may 
be overestimated for fraction sizes 
as small as 1 or 2 Gy, when calculated 
for the Linear-Quadratic (LQ) model fitted 
to the data obtained from fractions larger 
than 2 Gy. Reasons for this are unknown, 
but possible interpretations include ex-
haustion of repair capacity and incomplete 
repair in experiments designed to study 
the response to these small doses [1]. 
   Furthermore, further data suggest other-
wise, in view of the devasting effect of ra-
diation myelopathy, that one must not 
assume the spinal cord to have a greater 
tolerance at fraction sizes below 1.8 
to 2 Gy. 
   Further experimental data are desirable 
to confirm the validity of the LQ model 
at small doses per fraction and to cha-
racterize the repair kinetics at small doses 
per fraction. 
   At present, in clinical protocols of multi-
ple daily fractions, it is essential to space 
the fractions interfraction interval as 
(as long as) possible. In view of the deva-
sting effect of radiation myelopathy, repair 
of sublethal damage in the spinal cord 
or central nervous system cannot be rega-
rded to be complete even after an inter-
fraction interval of 8 hr. The repair kinetics 
in the spinal cord is slower than previously 
anticipated. Therefore there is no rationale 
to use interfraction intervals <6hr. 
   The appearance of radiation myelitis 
in patients receiving accelerated radiothe-
rapy has led to further laboratory expe-
riments, particularly those with a view 
to determining the half time of repair 
in neural tissues. Experiments suggest 
that there may be a component of repair 
in nervous tissues which may exceed 
4 hours. Such a component must be 
expected to increase the risk of radiation 
injury when two or more fractions are gi-
ven each day. When the half time of repair 
exceeds 4 hr, even an extension of the in-
terval between treatments to 8 hr, will still 
leave a considerable element of non-repa-
ired damage, and if all treatments are 
given as in CHART over a continuous 
12 day period, there will also be an accu-
mulation of non-repaired damage 
at the end of each treatment day. 
   The evidence now available suggests 
that in accelerated treatment, sparing 
of late damage in the spinal cord with 
the use of hyperfractionation does not 
occur and that when equal doses are gi-
ven, it is increased. Mathematical models 
based upon the analysis of laboratory 
and clinical data are extremely important 
in advancing our knowledge. 
   It is unfortunate that the standard pra-
ctice for listing incidental doses to the spi-
nal cord is determined more by litigation 
than by clinical judgement. Tumouricidal 
doses should never be compromised 
for the purpose of limiting the cord dose 
to 45 Gy. 
   Limiting the cord dose to 45 Gy in a hy-
perfractionation schedule leads to even 
greater likelihood of compromising the tu-
mour dose. Many credible experts have 
recommended 50 Gy in 2 Gy fractions 
as an acceptable spinal cord dose and this 
recommendation is probably conservative. 
   Even higher doses could be given 
if the clinical situation requires them and 
the patient is properly informed of the risk 
and the consequences of myelopathy. 
It is not by limiting the spinal cord dose 
that the incidence of myelopathy should 
be reduced, but rather by determining 
what factors in the patient's medical 
history and physical status make the spi-
nal cord more sensitive than expected. 
By controlling excessive risk factors, 
myelopathies can be kept to a minimum 
and the tumour dose can be prescribed 
to suit the disease. 
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